Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Targeted therapy in KITD816V-positive mastocytosis: waiting for proof-of-principle.

Leukemia & lymphoma - 1 Mar 2010

Tefferi Ayalew, Pardanani Animesh

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cell Proliferation
Share to Mastocytosis, Systemic
Share to Mutation
Share to Phenotype

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Proto-Oncogene Proteins c-kit

Share to Skin Diseases

Share to Treatment Outcome

Source

Identifiers

PMID: 20141434
DOI: 10.3109/10428190903586334

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Targeted therapy in KITD816V-positive mastocytosis: waiting for proof-of-principle.PMID 20141434Read ↗

Recent advances in the understanding and therapeutic management of mastocytosisSemantic proximity Read ↗

Systemic mastocytosis for the practicing clinician: overview, diagnostic features, prognostication and antiproliferative treatment in the era of targeted therapy.Semantic proximity Read ↗

KIT-Targeting Drugs in the Management of Nonadvanced and Advanced Systemic Mastocytosis.Semantic proximity Read ↗

Precision Medicine in Systemic Mastocytosis.Semantic proximity Read ↗

KIT mutation analysis in mast cell neoplasms: recommendations of the European Competence Network on Mastocytosis.Semantic proximity Read ↗

Tyrosine Kinase Inhibitors in the Treatment of Eosinophilic Neoplasms and Systemic Mastocytosis.Semantic proximity Read ↗

Tyrosine Kinase Inhibition in Mastocytosis: KIT and Beyond KIT.Semantic proximity Read ↗

The impact of sensitive KIT D816V detection on recognition of Indolent Systemic MastocytosisSemantic proximity Read ↗

Advanced systemic mastocytosis: the impact of KIT mutations in diagnosis, treatment, and progression.Semantic proximity Read ↗

KITD816V mutation in blood for the diagnostic screening of systemic mastocytosis and mast cell activation syndromes.Semantic proximity Read ↗

Molecular defects in mastocytosis: KIT and beyond KIT.Semantic proximity Read ↗

Kit Mutations: New Insights and Diagnostic Value.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.